Nano-Micro Letters上的综述需要邀稿才能投吗？没邀稿的情况下可以投吗
最近写了篇综述，想投Nano-Micro Letters，但是没有收到Nano-Micro Letters的综述邀稿。请问各位专家，综述文章在没收到邀稿的情况下可以直接投吗？是否需要提前写proposal发给编辑看下？

兄弟们，航空动力学报终审已经二十天了，是不是完蛋了啊，服了啊，等得花儿都谢了

期刊投稿，这项要填写什么呢？有没有了解的人传授一下经验呀

投稿到一个还不错的SSCI期刊，过了快一个月了还没有人接受审稿，这怎么办才好啊，投稿时也推荐了审稿人的
Reviews completed: 0
Review invitations accepted: 0
Review invitations sent: 2+

外校投的西交大学报，外审已经返修提交回去又进入外审。我看以前投稿的人外审返修提交回去没两天复审就喊版权转让，我这又变成外审状态，是不是凉了。外审意见一个是修改些格式问题，一个主要是增加点实验分析，都认真修改并做了详细的修改说明。每天都慌的不行

如题，而且预计完成时间是一个星期，现在都一个多星期了，有没有前辈了解情况啊，非常慌！

frontiers in pharmacology, jcr药学一区、中科院大类医学二区，小类药学二区，影响因子5.988 ，citescore： 6.6

肝病方向专题：pathophysiology and pharmacological treatments associated with liver failures，

abstract submission deadline: 30 june 2023, manuscript submission deadline: 02 october 2023

可以与期刊协商提供相应的文章处理费豁免，欢迎各位老师同学投稿！

pathophysiology and pharmacological treatments associated with liver failures.

about this research topic:
acute and chronic liver failures, which represent the loss of liver function, occupy the center stage of hepatic disorders as they are connected with a variety of liver diseases including fatty liver disease, cirrhosis, viral hepatitis, hepatocellular carcinoma and hepatic encephalopathy.
the clinical manifestations of liver failures are multifaceted and usually include fatigue, diarrhea, confusion, excess bleeding, and eventually death. in many cases, the only curative treatment option is liver transplantation. although it is generally accepted that liver failures occur under the influence of miscellaneous factors, the detailed molecular mechanisms of various liver failures and associated diseases have not been fully elucidated. since acute and chronic liver failures are major causes of morbidity and mortality globally, a detailed understanding of their associated pathogenesis is essential to improve the treatment options and outcomes in the context of limited liver transplantation.

currently, severe toxic, metabolic, viral, and autoimmune injuries are the mainstream theories regarding the causes of acute and chronic liver failures. reducing and limiting the influence of relevant precipitating factors, thus, are the main strategies for the treatment of liver failure-associated disorders. over the last decade, there is also emerging evidence indicating the contribution of aging, mitochondrial damage, cellular senescence, and autophagy inhibition in the development of liver failures.

this research topic will try to shed light on novel research elucidating the molecular and cellular pathogenesis of various liver diseases, as well as relevant intervention strategies. the aim is to bring together the latest findings on the pathogenesis mechanisms of liver failure-associated diseases and to propose future treatment strategies for acute and chronic liver failures.

the topic editors encourage researchers to submit original researches, brief research reports, systematic reviews, reviews, mini-reviews, and clinical trials relevant to the pathogenesis and management of liver diseases, including, but not limited to the following themes:

1. pathophysiology, pharmacology and intervention strategies of acute and chronic liver failures.

2. pathophysiology, pharmacology and intervention strategies of fatty liver diseases.

3. pathophysiology, pharmacology and intervention strategies of hepatocellular carcinoma.

4. pathophysiology, pharmacology and intervention strategies of liver disease-associated neurological complications.


why publish in our research topic?
alongside a top group of authors, your work will be published in frontiers in pharmacology, a leading journal in the field with a journal impact factor of 5.988 and a citescore of 6.6.

you can read more about the collection here:

please click the link to register your interest in submitting an article. we accept original researches, brief research reports, systematic reviews, reviews, mini-reviews, and clinical trials.

the deadline for submission is 02/10/2023, but frontiers’ fast-track review process, led by my editorial team, means each article is published online as soon as it’s been successfully peer-reviewed and accepted (typically within 61 days).  

as an open access journal, publishing fees are applied to accepted articles. please contact to discuss fees, institutional waivers, and discounts.   

the team at frontiers will be in touch over the next few days to explain more about contributing to the collection. if you have any other questions in the meantime, please let me know.  

i believe your insight will be a great addition to this topic, and i look forward to hearing more about your latest research.

有谁有 robotics and autonomous systems 期刊的word模板啊，投稿需要注意什么哇

请问AFM投稿时，短摘要，TOC图，和手稿放一个word提交吗？还是分开提交？谢谢大家

土壤学、农业资源等农学方向的cscd论文综述分享写作心得，交流研究课题等。

有偿求人帮忙画化合物chemdraw1996 快毕不了业了 急需 很简单的结构 二萜类 一元两个 有意者加V 18135711791

直接影响能不能毕业的一篇文章，希望能中

镁合金缓蚀剂方向，投稿意见中审稿人认为吸附等温线判断缓蚀剂的吸附类型是有争议的。请问大家，这在手稿中应该怎么修改啊？

求助各位大神 ACS Applied energy materials与Alloys and compounds哪个期刊更好呢？
    Applied energy的影响因子是6.9   但是其中科院分区属于三区，2018年创刊 且年收刊不到2000篇。                        
    Alloys and compounds影响因子6.3，中科院分区属于二区，1991年创刊 年收刊近6000篇。我的文章投Alloys and compounds比较稳但是感觉ACS Applied energy materials期刊质量更高，明年博士毕业，不知道投哪个好····

近期朋友组织了一个中科院大类二区TOP期刊《Molecules》（IF 4.9）的Special Issue: “Photocatalytic Materials and Photocatalytic Reactions”，
接收投稿时间从现在到今年十月底，稿件处理快，一经录用即见刊。
欢迎各位专家学者不吝赐稿。
网址